US 12,226,468 B2
Immunoreactive peptides
Jere McBride, Galveston, TX (US); and David Walker, Galveston, TX (US)
Assigned to Research Development Foundation, Carson City, NV (US)
Filed by Research Development Foundation, Carson City, NV (US)
Filed on Jun. 26, 2024, as Appl. No. 18/754,918.
Claims priority of provisional application 63/510,310, filed on Jun. 26, 2023.
Prior Publication US 2024/0424075 A1, Dec. 26, 2024
Int. Cl. A61K 39/02 (2006.01); A61K 39/39 (2006.01); C07K 14/29 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01)
CPC A61K 39/0233 (2013.01) [A61K 39/39 (2013.01); C07K 14/29 (2013.01); G01N 33/56911 (2013.01); A61K 2039/55566 (2013.01); C07K 2319/40 (2013.01); C07K 2319/41 (2013.01); C07K 2319/42 (2013.01); G01N 2333/29 (2013.01); G01N 2469/20 (2013.01)] 29 Claims
 
1. An immunoreactive polypeptide comprising SEQ ID NO:1 or SEQ ID NO:7, or a polypeptide at least 90% identical thereto.